CABG versus medical therapy for reduced EF

In this trial of patients with reduced ejection fraction (EF <35%) and anatomy amenable to CABG, they were randomized to CABG or medical therapy. Overall death was not significantly different between the groups, but those in medical therapy had significantly higher rates of cardiovascular death. CABG appears to be superior to medical therapy for reducing cardiovascular death (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment